apixaban

(redirected from Eliquis)
Also found in: Medical.
Related to Eliquis: Apixaban, Pradaxa, Xarelto
Translations

apixaban

n apixabán m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
The two companies were testing Eliquis, which includes apixaban, an orally-taken inhibitor which blocks a key blood-clotting protein, reducing the risk of thrombin generation and blood clots.
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the fourth quarter and full year of 2018 which were highlighted by strong demand for Opdivo (nivolumab) and Eliquis (apixaban) and a robust operating performance across the portfolio.
NEW YORK -- (BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the second quarter of 2019, which were highlighted by strong sales for Eliquis (apixaban) and Opdivo (nivolumab) and a robust operating performance across the portfolio.
Performance was primarily driven by 6% volume-driven operational growth in our Biopharma business, including continued growth of key brands such as Ibrance, Eliquis and Xeljanz as well as in emerging markets," said CEO Albert Bourla.
Within the DOAC-treated group, 42% received rivaroxaban (Xarelto), 26% dabigatran (Pradaxa), 24% apixaban (Eliquis), and 8% edoxaban (Savaysa).
Comments: Biopharma revenues were $9.2 billion, up 3% driven by Eliquis (+32% to $1.0 billion), Ibrance (+21% to $1.1 billion), Prevnar 13/Prevenar 13 (+8% to $1.5 billion) and Xeljanz (+30% to $423 million).
It will have a top five immunology and inflammation franchise led by Orencia and Otezla; and will have the #1 cardiovascular franchise led by Eliquis.
The procedure can be performed in your doctor's office, but it is not suitable for people who take blood thinners, such as warfarin (Coumadin), dabigatran (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa).
M2 PHARMA-March 19, 2019-The Bristol-Myers Squibb-Pfizer Alliance Shows Favourable Results from Trial of Eliquis Versus Vitamin K Antagonists
New blood thinners, such as rivaroxaban (Xarelto), dabigatran (Pradaxa), and apixaban (Eliquis), do not interact with vitamin K.
Anticoagulant Eliquis, which Pfizer markets with Bristol-Myers Squibb, will almost certainly be on that list.